The Clinical Operations team at Oncolytics Biotech is responsible for designing, implementing, and managing clinical trials to evaluate the safety and efficacy of REOLYSIN® in treating various cancers. This team ensures compliance with regulatory standards, collaborates with external partners, and oversees trial logistics to advance innovative treatments for solid tumors and hematological malignancies.